House Approves NCI’s First $4 Billion Budget, $22.8 Billion For NIH In FY2002.
Foundation Honors Three In Oncology; Society Wins Software Grant From Microsoft.
Arthur James, Ohio Founder Of Research Institute, Dead.
Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.
Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.
Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO